BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23532872)

  • 1. Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer.
    Wang L; Li L; Guo Y; Tong H; Fan X; Ding J; Huang H
    Prostate; 2013 Aug; 73(11):1147-58. PubMed ID: 23532872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents.
    Sanna V; Pintus G; Bandiera P; Anedda R; Punzoni S; Sanna B; Migaleddu V; Uzzau S; Sechi M
    Mol Pharm; 2011 Jun; 8(3):748-57. PubMed ID: 21545176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
    Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
    J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry.
    Zlitni A; Yin M; Janzen N; Chatterjee S; Lisok A; Gabrielson KL; Nimmagadda S; Pomper MG; Foster FS; Valliant JF
    PLoS One; 2017; 12(5):e0176958. PubMed ID: 28472168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging.
    Fan X; Wang L; Guo Y; Tu Z; Li L; Tong H; Xu Y; Li R; Fang K
    PLoS One; 2015; 10(6):e0127419. PubMed ID: 26111008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment.
    Cho HS; Dong Z; Pauletti GM; Zhang J; Xu H; Gu H; Wang L; Ewing RC; Huth C; Wang F; Shi D
    ACS Nano; 2010 Sep; 4(9):5398-404. PubMed ID: 20707381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
    Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
    Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity.
    Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
    Prostate; 2010 Sep; 70(12):1286-94. PubMed ID: 20623630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer.
    Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P
    Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofluorinated derivatives of 2-(phosphonomethyl)pentanedioic acid as inhibitors of prostate specific membrane antigen (PSMA) for the imaging of prostate cancer.
    Graham K; Lesche R; Gromov AV; Böhnke N; Schäfer M; Hassfeld J; Dinkelborg L; Kettschau G
    J Med Chem; 2012 Nov; 55(22):9510-20. PubMed ID: 23025786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner.
    Taylor RM; Sillerud LO
    Int J Nanomedicine; 2012; 7():4341-52. PubMed ID: 22915856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of luteinising-hormone releasing hormone nanoliposomal microbubbles specifically targeting ovarian cancer cells in vitro.
    Zhang J; Liu S; Zhu Y; Zhang L; Li W; Wang F; Huang S
    Mol Med Rep; 2014 Jul; 10(1):567-71. PubMed ID: 24805264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.
    Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W
    Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
    Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
    Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.
    Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U
    Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.
    Ma D; Hopf CE; Malewicz AD; Donovan GP; Senter PD; Goeckeler WF; Maddon PJ; Olson WC
    Clin Cancer Res; 2006 Apr; 12(8):2591-6. PubMed ID: 16638870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
    You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
    Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
    Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
    PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity focused ultrasound combined with herpes simplex virus thymidine kinase gene-loaded ultrasound-targeted microbubbles improved the survival of rabbits with VX₂ liver tumor.
    Zhou SJ; Li SW; Wang JJ; Liu ZJ; Yin GB; Gong JP; Liu CA
    J Gene Med; 2012; 14(9-10):570-9. PubMed ID: 22941868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer.
    Han D; Wu J; Han Y; Wei M; Han S; Lin R; Sun Z; Yang F; Jiao D; Xie P; Zhang L; Yang AG; Zhao A; Wen W; Qin W
    Oncotarget; 2016 Sep; 7(37):59471-59481. PubMed ID: 27448970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.